E-LIB Suche - Ergebnisse für: Choueiri, T.K.

1

Nivolumab plus cabozantinib versus sunitinib for first-line..:

Powles, T. ; Burotto, M. ; Escudier, B....
ESMO Open. 9 (2024) 5 - p. 102994 , 2024

Link: https://doi.org/10.1016/..

2

Characterization of patients with metastatic renal cell car..:

Takemura, K. ; Ernst, M. ; Navani, V....
European Urology. 83 (2023) - p. S473-S474 , 2023

Link: https://doi.org/10.1016/..

3

Extended follow-up from JAVELIN Renal 101: subgroup analysi..:

Haanen, J.B.A.G. ; Larkin, J. ; Choueiri, T.K....
ESMO Open. 8 (2023) 3 - p. 101210 , 2023

Link: https://doi.org/10.1016/..

4

Pharmacovigilance analysis of melanoma adverse events in me..:

Labban, M. ; Beatrici, E. ; Filipas, D.K....
European Urology. 83 (2023) - p. S1815 , 2023

Link: https://doi.org/10.1016/..

5

Comparison of the Genomic Alterations in Upper-tract and Bl..:

Yekeduz, E. ; Saliby, R.M. ; Shah, V....
European Urology Open Science. 57 (2023) - p. S11 , 2023

Link: https://doi.org/10.1016/..

6

COVID-19 in cancer patients: update from the joint analysis..:

Martin, P. ; Tsourti, Z. ; Ribeiro, J....
ESMO Open. 8 (2023) 3 - p. 101566 , 2023

Link: https://doi.org/10.1016/..

7

Efficacy of avelumab plus axitinib versus sunitinib by numb..:

Tomita, Y. ; Motzer, R.J. ; Choueiri, T.K....
ESMO Open. 8 (2023) 6 - p. 102034 , 2023

Link: https://doi.org/10.1016/..

8

COVID-19 in patients with cancer: first report of the ESMO ..:

Castelo-Branco, L. ; Tsourti, Z. ; Gennatas, S....
ESMO Open. 7 (2022) 3 - p. 100499 , 2022

Link: https://doi.org/10.1016/..

9

Safety and Efficacy of Stereotactic MRI-Guided Adaptive Rad..:

Yim, K. ; Cagney, D.N. ; Mak, R.H....
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 3 - p. e207 , 2022

Link: https://doi.org/10.1016/..

10

76P Safety profile of adjuvant pembrolizumab (pembro) in me..:

Luke, J.J. ; Long, G.V. ; Robert, C....
Immuno-Oncology and Technology. 16 (2022) - p. 100180 , 2022

Link: https://doi.org/10.1016/..

11

Sustainable multidisciplinary team referral for non-metasta..:

Basile, G. ; Rosiello, G. ; Fallara, G....
European Urology. 81 (2022) - p. S1470-S1471 , 2022

Link: https://doi.org/10.1016/..

12

Efficacy and safety of avelumab plus axitinib in elderly pa..:

Tomita, Y. ; Motzer, R.J. ; Choueiri, T.K....
ESMO Open. 7 (2022) 2 - p. 100450 , 2022

Link: https://doi.org/10.1016/..

13

64P Safety and efficacy of immune checkpoint inhibitors (IC..:

Nassar, A.H. ; Zarif, T. ; Abou Alaiwi, S....
Immuno-Oncology and Technology. 16 (2022) - p. 100169 , 2022

Link: https://doi.org/10.1016/..

14

Association of C-reactive protein with efficacy of avelumab..:

Tomita, Y. ; Larkin, J. ; Venugopal, B....
ESMO Open. 7 (2022) 5 - p. 100564 , 2022

Link: https://doi.org/10.1016/..

15

Efficacy and correlative analyses of avelumab plus axitinib..:

Choueiri, T.K. ; Larkin, J. ; Pal, S....
ESMO Open. 6 (2021) 3 - p. 100101 , 2021

Link: https://doi.org/10.1016/..